Analyst firms · Robert W. Baird · GERN

Robert W. Baird GERN price target and rating history

Geron Corporation (GERN) · Health Care

Robert W. Baird rates Geron Corporation (GERN) Neutral with a $4.50 price target, as of its latest action on Apr 30, 2024. It has published 3 rating actions on GERN since November 2021, including 0 upgrades and 1 downgrade.

Current rating
Neutral
Price target
$4.50
Median target, all firms
Too few
Actions on GERN
3

Robert W. Baird price target on GERN

$4.50$4.25$420222023202420252026
Robert W. Baird price target on GERN, each point a stated target, November 2021 to April 2024.

Every Robert W. Baird rating on GERN

Questions about Robert W. Baird and GERN

What is Robert W. Baird's price target for GERN?
Robert W. Baird's latest stated price target for Geron Corporation (GERN) is $4.50, from its action on Apr 30, 2024.
What is Robert W. Baird's rating on GERN?
Robert W. Baird rates GERN Neutral, a neutral rating, as of Apr 30, 2024.
When did Robert W. Baird last change its view on GERN?
On Apr 30, 2024, Robert W. Baird downgrades to Neutral from Outperform, price target $4.50.

More GERN rating histories

All Robert W. Baird ratingsGERN news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.